Strata Critical Medical, Inc.
SRTA
$4.14
-$0.11-2.59%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 66.79M | 49.30M | 26.75M | 54.31M | 36.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.79M | 49.30M | 26.75M | 54.31M | 36.39M |
| Cost of Revenue | 55.12M | 37.68M | 20.89M | 42.33M | 31.37M |
| Gross Profit | 11.67M | 11.61M | 5.86M | 11.98M | 5.01M |
| SG&A Expenses | 13.99M | 11.74M | 6.66M | 18.75M | 15.46M |
| Depreciation & Amortization | 2.60M | -- | -- | -- | 1.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 70.35M | 49.88M | 27.63M | 61.89M | 47.06M |
| Operating Income | -3.57M | -577.00K | -883.00K | -7.58M | -10.67M |
| Income Before Tax | -5.39M | -9.66M | -1.51M | -3.51M | -7.43M |
| Income Tax Expenses | -- | -- | -- | -17.00K | -- |
| Earnings from Continuing Operations | -5.39M | -9.66M | -1.53M | -3.49M | -7.43M |
| Earnings from Discontinued Operations | -3.45M | 67.07M | -- | -- | -2.36M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.83M | 57.42M | -3.74M | -3.49M | -9.79M |
| EBIT | -3.57M | -577.00K | -883.00K | -7.58M | -10.67M |
| EBITDA | -558.00K | -158.00K | 893.00K | -5.89M | -9.60M |
| EPS Basic | -0.10 | 0.70 | -0.05 | -0.04 | -0.12 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | -0.03 | -0.10 |
| EPS Diluted | -0.10 | 0.69 | -0.05 | -0.04 | -0.13 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | -0.03 | -0.10 |
| Average Basic Shares Outstanding | 84.70M | 82.45M | 80.61M | 79.89M | 78.54M |
| Average Diluted Shares Outstanding | 84.70M | 82.45M | 80.61M | 79.89M | 78.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |